Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin

Journal of the American College of Cardiology

Volumn 27, Issue 6, 1996, Pages 1497-1501

  Porter, Thomas R ^a   Xie, Feng ^a   Kricsfeld, David ^a   Armbruster, Robert W ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FLUOROCARBON; GLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; ULTRASOUND;

EID: 0029927502     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00017-4     Document Type: Article

References (15)

1. Villanueva F, Glasheen WP, Sklenar J. Jayaweera AR, Kaul S. Successful and reproducible myocardial opacification during two-dimensional echocardiography from right heart injection of contrast. Circulation 1992;85:1557-64.
2. Villaneuva F, Glasheen WP, Sklenar J, Kaul S. Assessment of risk area coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation 1993;88:596-604.
3. Porter T, Xie F. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases. J Am Coll Cardiol 1995;25-2:509-15.
4. Dittrich HC, Bales GL, Kuvelas T, Hunt RM, McFerran BA, Greener Y. Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent. J Am Soc Echocardiogr 1995;8:465-74.
5. Grauer S, Pantely GA, Xu J. et al. Aerosomes ® MRX 115: echocardiographic and hemodynamic characteristics of new echo contrast agent that produces myocardial opacification after intravenous injections in pigs [abstract]. Circulation 1994;90(Pt 2) :I-556.
6. Porter TR, Xie F, Kricsfeld A. Myocardial ultrasound contrast with intravenous perfluoropropane-enhanced sonicated dextrose albumin: initial clinical experience in humans. J Am Coll Cardiol 1995;25:39A.
7. Starritt HC, Duck FA, Hawkins AJ, Humphrey VF. The development of harmonic distortion in pulsed finite-amplitude ultrasound passing through liver. Phys Med Biol 1986;31:1401-9.
8. De Jong N, Ten Cate FJ, Lancee CT, Roelandt JR, Bom N. Principles and recent developments in ultrasound contrast agents. Ultrasonics 1991;29:324-30.
9. Scrope BA, Newhouse VL. Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol 1993;19:567.
10. Porter TR, Xie F. Transient myocardial contrast following initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms. Circulation 1995; 92:2391-5.
11. Mor-Avi V, Robinson K, Shroff S, Lang RM. Stability of albunex microspheres under ultrasonic irradiation: an in vitro study. J Am Soc Echocardiogr 1994;7:S29.
12. Vandenberg BF, Melton HE. Acoustic liability of albumin microspheres. J Am Soc Echocardiogr 1994;7:582-9.
13. Wray RA, Zoghbi WA, Quinones MA, Cheirif J. Contrast echocardiography: relation of acoustic power and time gain compensation to contrast intensity duration. J Am Soc Echocardiogr 1992;4:286.
14. Crum LA, Roy RA, Dinno MA, et al. Acoustic cavitation produced by microsecond pulses of ultrasound: a discussion of some selected results. J Acoust Soc Am 1992;91(2):1113-9.
15. Roy RA, Church CC, Calabrese A. Cavitation produced by short pulses of ultrasound. In: Hamilton AF, Blackstock DT, editors. Frontiers of Nonlinear Acoustics: Proceedings of 12th International Symposium of Nonlinear Acoustics. London: Elsevier, 1990:476-81.